| | | | | | | | | | |
|
|
|
|
| Dockets Entered
On July 6, 2005
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1975N-0256
|
| Food Labeling & Label Declaration of Ingredient Requireme
|
|
|
|
|
| 1996P-0230
|
| Grant exception for label declaration of ingredients/b olive
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| 2004D-0333
|
| Emergency Use Authorization of Medical Products
|
|
|
|
|
| 2004N-0432
|
| Radioactive Drugs for Certain Research Uses; Public Meeting
|
|
|
|
|
| 2004N-0463
|
| Food Labeling: Prominence of Calories
|
|
|
|
|
| 2004N-0539
|
| Establishing a Docket for the Development of Plasma Standards Public Workshop; Availability
|
|
|
|
|
| 2004P-0353
|
| ANDA Suitability for Famotidine Orally Dissolving Strips 10 mg
|
|
|
|
|
| 2004P-0373
|
| ANDA for Omeprazole Magnesium Delayed Release Capsules,Eq. to 20 mg base for OTC
|
|
|
|
|
| 2005N-0157
|
| Agency Information Collection Activities: Proposed Collection; Postmarketing Adverse Drug Experience Reporting
|
|
|
|
|
| 1975N-0256
|
| Food Labeling & Label Declaration of Ingredient Requireme
|
|
|
|
|
| C 508
|
| Mrs. Thomas J. Curran
|
| Vol #:
|
| 1
|
|
|
|
|
| 1996P-0230
|
| Grant exception for label declaration of ingredients/b olive
|
|
|
|
|
| LET
2
|
| HFS-822 to Hyman, Phelps & McNamara, P.C.
|
| Vol #:
|
| 1
|
|
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
|
|
| C 7492
|
| J. Kahl
|
| Vol #:
|
| 319
|
|
|
|
|
| 2004D-0333
|
| Emergency Use Authorization of Medical Products
|
|
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
| |
|
| 2004N-0432
|
| Radioactive Drugs for Certain Research Uses; Public Meeting
|
|
|
|
|
| C
7
|
| Harvard Medical School
|
| Vol #:
|
| 2
|
|
|
|
|
| C 8
|
| S. Kaste, DO
|
| Vol #:
|
| 2
|
|
|
|
|
| 2004N-0463
|
| Food Labeling: Prominence of Calories
|
|
|
|
|
| C 46
|
| F. Levin
|
| Vol #:
|
| 4
|
|
|
|
|
| C
47
|
| AARP
|
| Vol #:
|
| 4
|
|
|
|
|
| 2004N-0539
|
| Establishing a Docket for the Development of Plasma Standards Public Workshop; Availability
|
|
|
|
|
| C
2
|
| Plasma Protein Therapeutics Assn (PPTA)
|
| Vol #:
|
| 1
|
|
|
|
|
| C
3
|
| European Pharmacopoeia (EU)
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0353
|
| ANDA Suitability for Famotidine Orally Dissolving Strips 10 mg
|
|
|
|
|
| PAV
1
|
| HFD-600 to Lachman Consultant Services, Inc.
|
| Vol #:
|
| 1
|
|
| |
|
| 2004P-0373
|
| ANDA for Omeprazole Magnesium Delayed Release Capsules,Eq. to 20 mg base for OTC
|
|
